Infleqtion wins DOE Genesis Mission projects for nuclear research
Infleqtion Inc. secured three U.S. Department of Energy Genesis Mission projects to advance nuclear research and quantum sensing, collaborating with national laboratories. The stock rose 3.13% to $10.19, though technical indicators suggest a continued downtrend with shares down 35.1% over the past year.

*this image is generated using AI for illustrative purposes only.
Infleqtion Inc. (NYSE: INFQ) stock rose 3.13% to $10.19 on Wednesday after the quantum technology company secured three projects from the U.S. Department of Energy (DOE) for the Genesis Mission. The awards aim to accelerate American scientific research and innovation in nuclear applications, deployable atomic quantum sensing, and nuclear fusion energy. Despite the recent gains, the stock remains in a longer-term downtrend, having fallen 35.1% over the past 12 months.
The Genesis Mission is a national initiative building an integrated science discovery platform that combines AI, supercomputing, quantum systems, and advanced scientific instruments. The Phase I RFA awards focus on identifying pathways for transformative scientific capabilities. Project teams will design workflows integrating AI with scientific investigation to evaluate if these approaches can accelerate discovery and improve predictive capabilities.
Project Collaborations
The partnerships leverage Infleqtion's neutral-atom technology to advance capabilities in critical scientific domains. The following table outlines the primary focus areas and collaborating entities:
| Focus Area | Collaborating Entities |
|---|---|
| AI-optimized quantum circuit design for nuclear applications | Argonne National Laboratory, Infleqtion |
| Deployable atomic quantum sensing with Agentic AI | Brookhaven National Laboratory, Infleqtion |
| Nuclear fusion energy research | Lawrence Livermore National Laboratory, University of Colorado Boulder, Infleqtion |
Strategic Context
"By applying quantum computing to some of the hardest problems in nuclear and energy research, Infleqtion is playing a critical role in advancing the objectives of the Genesis Mission," said Matthew Kinsella, CEO at Infleqtion. The awards follow a recent Letter of Intent with the U.S. Department of Commerce outlining a potential investment of up to $100 million to expand U.S. quantum capabilities.
Technical Analysis
Despite Wednesday's rebound, Infleqtion remains in a longer-term downtrend. Shares traded about 11.6% below the 20-day simple moving average of $11.45, 24% below the 50-day average of $13.31, and 19.6% below the 100-day average of $12.59. The 20-day average remains below the 50-day average, signaling that the intermediate trend is still negative. Momentum indicators remain cautious, with the moving average convergence divergence (MACD) indicator below its signal line. A sustained move above the $12 level could improve the technical outlook, while support sits near $8.50, close to the stock's 52-week low of $8.52.
What specific milestones must be achieved during Phase I to secure subsequent funding for the Genesis Mission projects?
How might the finalized agreement with the U.S. Department of Commerce impact Infleqtion's production capacity and operational timeline?
What are the potential commercial applications for the deployable atomic quantum sensing technology developed with Brookhaven National Laboratory?





























